Kosten des chronischen unspezifischen Kreuzschmerzes in Österreich – eine Untersuchung an Patienten in aktueller Behandlung

Wagner, Ernst

doi:10.1007/s10354-011-0050-3

Cited by 5 publications

(5 citation statements)

References 17 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In comparison with another Austrian study measuring the direct costs of chronic low back pain in 2008 (EUR 1837 in 2008) [11], total direct medical costs were considerably higher in this study. Despite methodological discrepancies between the two analyses, inpatient rehabilitation and out-of-pocket costs were also found to be the most expensive cost factor in this earlier study [11], which is consistent with our findings. Compared to our study, total costs from the societal perspective were found to be lower in a Portuguese study (EUR 1883 in 2010) and in a Swedish study (EUR 6429 in 2008) [12, 14].…”

Section: Discussioncontrasting

confidence: 81%

“…To assess the societal and economic impact of chronic pain, several cost-of-illness studies have been conducted across Europe (e.g. [11–17]). Differences in methodologies, costing approaches and populations, however, make comparisons across studies difficult.…”

Section: Introductionmentioning

confidence: 99%

“…Most studies focus on direct medical costs with or without including broader societal costs such as productivity loss or informal care (e.g. [11–14, 17]). Although their inclusion is vital to reflect the societal burden comprehensively [1, 18], only a few previous studies (e.g.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The societal costs of chronic pain and its determinants: The case of Austria

et al. 2019

View full text Add to dashboard Cite

Background Chronic pain is among the most burdensome conditions. Its prevalence ranges between 12% and 30% in Europe, with an estimated 21% among Austrian adults. The economic impact of chronic pain from a societal perspective, however, has not been sufficiently researched. This study aims to provide an estimate of the societal costs for working-age adults with chronic pain in Austria. It explores the impact of sex, number of pain sites, selfreported pain severity, health literacy and private health insurance on costs associated with chronic pain. Methods A bottom-up cost-of-illness study was conducted based on data collected from 54 adult patients with chronic pain at three Viennese hospital outpatient departments. Information on healthcare costs including out-of-pocket expenses and productivity losses due to absenteeism and informal care were collected over 12 months. Resource use estimates were combined with unit costs and mean costs per patient were calculated in € for year 2016. Results Mean annual societal costs were estimated at EUR 10191. Direct medical costs were EUR 5725 including EUR 1799 out-of-pocket expenses (mainly pain relieving activities and private therapy). Productivity losses including informal care amounted to EUR 4466. Total costs for women and patients with three or more pain sites were significantly higher. No association with health literacy was found but there was a tendency towards higher out-ofpocket expenses for patients with complementary private health insurance. Conclusion This study is the first to provide a comprehensive assessment of the individual and societal burden of chronic pain in Austria. It highlights that chronic pain is associated with substantial

show abstract

Section: Discussioncontrasting

confidence: 81%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The societal costs of chronic pain and its determinants: The case of Austria

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Diseases of the respiratory system (J00–J99) Bronchial AsthmaBULIvanova et al [20] a 2014112Hospital costRetrospective chart review200–393 c 200–393 c NRNR2.8-5.5% COPDBULROUKyuchukov et al [21] a Stâmbu et al [37]NR20068485Hospital and patientNRProspective cohortInterview data183921038982103NRNRNRNR25.9%21.9% Lower respiratory tract infectionBULGlogovska et al [19] a NR1441 ambulatory + 353 hospitalizedHealth systemNRNR1218NRNR17.2% PneumoniaCZEHUNPOLSVKTichopad et al [76]2010258NR198315NRClaims dataAges 50–64/> 651194/7861009/686714/4721685/1111Ages 50–64/age > 65708/786686/686472/4721190/1111Ages:50-64/> 65486/0323/0242/0495/06.6%/4.3%8.0%/5.4%5.9%/3.9%10.8%/7.1% Streptococcus pneumoniae ROUStoicescu et al [93]200448,200Public payerClaims data8.3 million8.3 millionNRNRNAXIII. Diseases of the musculoskeletal system and connective tissue (M00.0–M99.9) Chronic non-specific back painAUTWagner et al [64] a 200848…”

Section: Methodsmentioning

confidence: 99%

Cost-of-illness studies in nine Central and Eastern European countries

et al. 2019

View full text Add to dashboard Cite

Background To date, a multi-country review evaluating the cost-of-illness (COI) studies from the Central and Eastern European (CEE) region has not yet been published. Our main objective was to provide a general description about published COI studies from CEE. Methods A systematic search was performed between 1 January 2006 and 1 June 2017 in Medline, EMBASE, The Cochrane Library, CINAHL, and Web of Science to identify all relevant COI studies from nine CEE countries. COI studies reporting costs without any restrictions by age, co-morbidities, or treatment were included. Methodology, publication standards, and cost results were analysed. Results We identified 58 studies providing 83 country-specific COI results: Austria ( n = 9), Bulgaria ( n = 16), Croatia ( n = 3), the Czech Republic ( n = 10), Hungary ( n = 24), Poland ( n = 11), Romania ( n = 3), Slovakia ( n = 3), and Slovenia ( n = 4). Endocrine, nutritional, and metabolic diseases (18%), neoplasms (12%), infections (11%), and neurological disorders (11%) were the most frequently studied clinical areas, and multiple sclerosis was the most commonly studied disease. Overall, 57 (98%) of the studies explicitly stated the source of resource use data, 45 (78%) the study perspective, 34 (64%) the costing method, and 24 (58%) reported at least one unit costs. Regardless of methodological differences, a positive relationship was observed between costs of diseases and countries’ per capita GDP. Conclusions Cost-of-illness studies varied considerably in terms of methodology, publication practice, and clinical areas. Due to these heterogeneities, transferability of the COI results is limited across Central and Eastern European countries. Electronic supplementary material The online version of this article (10.1007/s10198-019-01066-x) contains supplementary material, which is available to authorized users.

show abstract

“…These issues as well as the growing prevalence put LBP as a major public health problem, associated with increasing costs for social systems. Results of a recent Austrian study looking into societal costs linked to chronic pain issues reported overall annual costs of 10,191 Euros per patient, with inpatient rehabilitation, and out-of-pocket costs being identified as the two most expensive costs factors, the latter being also the conclusion of a 2008 Austrian study [11, 12].…”

Section: Introductionmentioning

confidence: 99%

Association between low back pain and various everyday performances

Grabovac

Dörner

2019

Wien Klin Wochenschr

101

View full text Add to dashboard Cite

SummaryLow back pain (LBP) is a widely prevalent chronic pain disorder associated with a high burden on individuals and society. In the subjective perception of patients with LBP, probably the most important health outcomes associated with LBP are those that effect everyday performance. Such outcomes include reduction in activities of daily living (ADL), in work ability (WA), and in sexual function. This narrative review aimed to (1) examine the association between LBP and the three mentioned outcomes of everyday performance, (2) to explain possible mediating factors promoting these associations, and (3) to discuss possible implications for treatment and rehabilitation. Studies have shown that LBP can generate anxiety of movement leading to movement avoidance (fear-avoidance beliefs), which may lead to deconditioning and further increasing problems with ADL, WA and decreasing sexual function. Furthermore, common mental disorders, such as depression, anxiety, and stress-related disorders, which also often co-occur with LBP can lead to adverse effects on everyday performance and vice versa, can be the consequence of such problems and aggravate LBP. Although there is no universally accepted treatment modality that fits every patient with LBP, physical training, comprehensive patient education, and workplace or home modifications have been shown to be able to interrupt the mutual influence between LBP and the described mediating factors, and have a beneficial effect on ADL, WA, and sexual function. For this, a multidisciplinary approach is necessary which includes multiprofessional care teams, participation of the patients, and involvement of different settings, such as workplace, home, and physical training facilities.

show abstract

Kosten des chronischen unspezifischen Kreuzschmerzes in Österreich – eine Untersuchung an Patienten in aktueller Behandlung

Cited by 5 publications

References 17 publications

The societal costs of chronic pain and its determinants: The case of Austria

The societal costs of chronic pain and its determinants: The case of Austria

Cost-of-illness studies in nine Central and Eastern European countries

Association between low back pain and various everyday performances

Contact Info

Product

Resources

About